SDC4 and intervertebral disk degenerative disorder: Ge et al. [76] observed that syndecan-4 effectively activates JNK and its downstream p53 pathway, which is accompanied by decreased protein expression levels of type II collagen and aggrecan and increased expression levels of collagen X, which exacerbates the IDD process.